| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC2904 | Kca-1490 | Dual PDE3/4 inhibitor |
|
| DCC2905 | Kca2 Positive Modulator 2q | Novel potent and Subtype-Selective Positive Modulator of KCa2 Channels |
|
| DCC2906 | Kcal01 | Potent PDZ domain peptide inhibitor that rescues CFTR activity |
|
| DCC2907 | Kdm4c-in-35 | Novel selective KDM4C inhibitor |
|
| DCC2908 | Kdm4-in-i | Novel KDM4 inhibitor |
|
| DCC2909 | Kdoam-20 | Potent and selective KDM5 inhibitor |
|
| DCC2910 | Kdoam-21 | Potent and selective KDM5 inhibitor |
|
| DCC2911 | Kemptide Acetate Salt | Phosphate acceptor peptide substrate for cAMP-dependent protein kinase |
|
| DCC2912 | Kf15372 | Potent and selective adenosine A1 antagonist with renal protective and diuretic activities |
|
| DCC2913 | Kfa1982 | Novel and potent factor Xa inhibitor |
|
| DCC2914 | Kgchm07 | Novel potent peptide dual agonist of opioid/neurokinin 1 receptor |
|
| DCC2915 | Kh-carb13 Hydrochloride | Novel Pim-1 kinase Inhibitor, dose-dependent decreasing the viability of LS174T and HCT-116 cells |
|
| DCC2916 | Khg21834 | Inhibitor of Aβ-induced inflammation |
|
| DCC2917 | Khg26693 | Novel anti-inflammatory and antioxidant agent, significantly decreasing blood glucose, triglycerides, and cholesterol and increased insulin |
|
| DCC2918 | Ki23057 | Novel FGFR2 inhibitor, enhancing the chemosensitivity of drug-resistant gastric cancer cell lines |
|
| DCC2919 | Kif18a Inhibitor 23 | Novel KIF18A inhibitor, causing significant mitotic arrest in vivo, binding at the interface of KIF18A and tubulin |
|
| DCC2920 | Ki-ms2-008 | Novel Max-binding modulator, attenuating Myc-driven transcription and stabilizing the Max homodimer |
|
| DCC2921 | kin100 | Novel inducer of the ISG54 promoter, causing IRF-3 translocation |
|
| DCC2922 | Kir1.1-in-a | Novel potent and selective inhibitor of kir1.1 channels |
|
| DCC2923 | Kist301072 | Novel ROS1 kinase inhibitor |
|
| DCC2924 | Kist301080 | Novel ROS1 kinase inhibitor |
|
| DCC2925 | Kjm429 | Novel TRPV1 antagonist |
|
| DCC2926 | Kj-pyr-10 | Novel specific inhibitor of MYC |
|
| DCC2927 | Kkha-761 | Potent D3 receptor antagonist with high 5-HT1A receptor affinity |
|
| DCC2928 | Kl-1156 | Novel NF-κB inhibitor and lipopolysaccharide (LPS)-induced nitric oxide production inhibitor |
|
| DCC2929 | Kld-12 | Self-assembling peptide, forming a hydrogel matrix to support growth of cells in the presence of an ionic solution, enhancing chondrogenic differentiation of bone marrow stromal cells (BMSCs) |
|
| DCC2930 | Klebsazolicin | Novel inhibitor of 70S ribosome by obstructing the peptide exit tunnel |
|
| DCC2931 | Klk6-in-32 | First-in-class inhibitor of Kallikrein-related peptidase 6 (KLK6), promoting the differentiation of OPCs into mature oligodendrocytes in vitro |
|
| DCC2932 | Klk6-in-42 | First-in-class inhibitor of Kallikrein-related peptidase 6 (KLK6), promoting the differentiation of OPCs into mature oligodendrocytes in vitro |
|
| DCC2933 | Kl-l9p | Novel antibiotic sensitizer, promoting the rearrangement of the bacterial membrane that enables hydrophobic antibiotics to permeate, strongly sensitizing Gram-negative bacteria to linezolid (Lzd), rifampicin (Rif), or clarithromycin (Clr) |
|
